Who needs to know?
Physicians prescribing anti-hyperglycaemic agents should consider hypoglycaemia risk, particularly amongst those with heightened cardiovascular risk.
Results
Hypoglycaemia is associated with significant QTc interval prolongation compared to euglycaemia (p=0.001). Hypoglycaemia triggers a reduction in heart rate variability.
